tm logo
ROMVIMZA
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 24 Oct 2024

Last Applicant/ Owned by

200 Smith Street

Waltham

MA

02451

Serial Number

98817650 filed on 24th Oct 2024

Registration Number

N/A

Correspondent Address

Karen Won

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ROMVIMZA

Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98817650

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 062902-400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
24th Oct 2024NEW APPLICATION ENTERED